Category: BioTech

BioTech, Stock Movers

AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market

Shares of AstraZeneca plc (ADR)(NYSE:AZN) reached a new high in pre-market trading as Pfizer Inc.(NYSE:PFE) confirmed it has attempted to renew negotiations on a possible merger. Pfizer submitted a preliminary indication of interest to the board of directors of AstraZeneca in January 2014 regarding the possible merger. AstraZeneca declined to pursue negotiations at that time, but Pfizer contacted AstraZeneca on April 26, 2014, seeking to renew … Continue reading AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market

Chris Lewis
BioTech, Services Sector, Software

Sonic Beats on Q2 Earnings, In Line on Revenue

Sonic (NASDAQ:SONC) reported Q2 earnings of $0.07 per share, up from $0.05 per share last year and a penny better than the analyst consensus on Capital IQ. System-wide same-store sales increased 1.4%, consisting of an increase of 1.5% at franchise drive-ins and an increase of 1.3% at company drive-ins. Total revenue was $109.7 million, down from $111.1 million last year and about in line with … Continue reading Sonic Beats on Q2 Earnings, In Line on Revenue

Mark DeFrance
BioTech

Biotech Volatile Stocks: CytRx Corporation (NASDAQ:CYTR), Synta Pharmaceuticals (NASDAQ:SNTA), Idenix Pharmaceuticals (NASDAQ:IDIX), CEL-SCI Corporation (NYSEMKT:CVM)

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of CytRx Corporation (NASDAQ:CYTR) common stock during the period between November 22, 2013 and March 13, 2014, inclusive (the “Class Period”). CytRx Corporation (NASDAQ:CYTR) stock performance was 0.00% in last session and finished the day … Continue reading Biotech Volatile Stocks: CytRx Corporation (NASDAQ:CYTR), Synta Pharmaceuticals (NASDAQ:SNTA), Idenix Pharmaceuticals (NASDAQ:IDIX), CEL-SCI Corporation (NYSEMKT:CVM)

John Bellich
BioTech

Biotech New Highs: BioSpecifics Technologies (NASDAQ:BSTC), Five Prime Therapeutics (NASDAQ:FPRX), IGI Laboratories (NYSEMKT:IG), Durata Therapeutics (NASDAQ:DRTX)

BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications. BioSpecifics Technologies Corp. (NASDAQ:BSTC) stock performance was 2.14% in last session and finished the day at $27.16. Traded volume was 61,391.00 shares in the last session and the average volume of the stock remained 27,510.00 shares. The beta of the stock remained 0.90. BioSpecifics Technologies Corp. … Continue reading Biotech New Highs: BioSpecifics Technologies (NASDAQ:BSTC), Five Prime Therapeutics (NASDAQ:FPRX), IGI Laboratories (NYSEMKT:IG), Durata Therapeutics (NASDAQ:DRTX)

Colin Pettis
BioTech

Biotech Losers: Egalet Corp (NASDAQ:EGLT), Marina Biotech (OTCMKTS:MRNA), Conatus Pharmaceuticals (NASDAQ:CNAT), Acceleron Pharma (NASDAQ:XLRN)

Egalet Corporation (NASDAQ:EGLT) announced that its fourth quarter and year ended December 31, 2013 financial results will be released on Wednesday, March 26, 2014. Egalet Corp (NASDAQ:EGLT) stock performance was -5.53% in last session and finished the day at $17.41. Traded volume was 82,789.00 shares in the last session and the average volume of the stock remained 196,859.00 shares. The beta of the stock remained … Continue reading Biotech Losers: Egalet Corp (NASDAQ:EGLT), Marina Biotech (OTCMKTS:MRNA), Conatus Pharmaceuticals (NASDAQ:CNAT), Acceleron Pharma (NASDAQ:XLRN)

Richard Atkins
BioTech

Biotech Gainers: Geron Corporation (NASDAQ:GERN), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Opexa Therapeutics Inc. (NASDAQ:OPXA)

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Geron Corporation (NASDAQ:GERN) securities during the period between June 16, 2013 and March 11, 2014, inclusive (the “Class Period”). Geron Corporation (NASDAQ:GERN) stock performance was 39.33% in last session and finished the day at … Continue reading Biotech Gainers: Geron Corporation (NASDAQ:GERN), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Opexa Therapeutics Inc. (NASDAQ:OPXA)

John Bellich